Results for: Ranibizumab Injection
Find the latest Ranibizumab Injection tenders from different organizations. SigmaTenders helps you participate in these online e-Procurement tenders. We provide access to tender details, BOQs, and technical bids, along with bidding support for Ranibizumab Injection e-tenders. Stay informed with daily email alerts and comprehensive coverage across government websites, GeM, and e-Procurement portals.
Supply of injection ranibizumab 10 mg/ml for opthalmic use
Injection ranibizumab 10 mg/ml for opthalmic use
ποΈβπ¨οΈ Bid Invitation: Supply of Injection Ranibizumab π The Directorate of Purchase and Stores, under the Central Government's Ministry/Department, is seeking bids for the supply of Injection Ranibizumab 10 mg/ml for ophthalmic use. π₯π©ββοΈ Bid Submission Deadline: May 02, 2024, 12:00 PM EMD: INR 55572 Interested bidders are requested to submit detailed bids, including pricing, delivery schedules, and compliance with pharmaceutical standards. The bid should be submitted to ASO Barc Hospital, Anushaktinagar, Mumbai. Keywords: Injection Ranibizumab, Ophthalmic Use, Pharmaceutical Supplies, Government Tender, Central Govt. Ministry/Department, Bid Submission, EMD
Ranibizumab intra-vitreal injection 10 mg/ml, 0.23 ml vial/0.165 ml pfs
For complete deion and other details, please refer to tender
Rate for ranibizumab 10 mg/ml injection & bevacizumab 25mg/ml injection (only railway registered manufacturing firms product will be accepted )
Rate for ranibizumab 10 mg/ml injection & bevacizumab 25mg/ml injection (only railway registered manufacturing firms product will be accepted )
Ranibizumab intra vitreal injection - vial/pfs 1.wet age related macular degeneration 2.diabetic macular edema 3.proliferative diabetic retinopathy 4.retinal vascular occlusion 5.myopic choroidal neovascularization 6.retinopathy of prematurity
For complete deion and other details, please refer to tender
Running contract for inj. ranibizumab (10mg/ml)) (0.23mg/0.23ml) for intravitreal injection vial, the medicine should be approved by dcgi for wet armd, diabetic macular oedema, rvo, myopic cnvm, pdr and rop.
For complete deion and other details, please refer to tender
π Invitation for Bid: Ranibizumab Injection Vial ππ The Ministry of Railways, under the Central Government, invites bids for a running contract to supply Inj. Ranibizumab (10mg/ml) vials. π₯ The medicine is indicated for various ocular conditions including wet Age-related Macular Degeneration (AMRD), Diabetic Macular Oedema (DMO), Retinal Vein Occlusion (RVO), Myopic Choroidal Neovascularization (CNVM), Proliferative Diabetic Retinopathy (PDR), and Retinopathy of Prematurity (ROP). ποΈ π Bid Submission Deadline: June 20, 2024, 2:00 PM A bid security of INR 5,43,50 is required. Interested pharmaceutical companies must ensure their bids comply with the Drug Controller General of India (DCGI) approval and other tender specifications. Keywords: Ranibizumab, Injection, Vial, DCGI Approved, Ocular Diseases, Ministry of Railways, Government Tender, Pharmaceutical Supplies
Ranibizumab intra vitreal injection - vial/pfs 1.wet age related macular degeneration 2.diabetic macular edema 3.proliferative diabetic retinopathy 4.retinal vascular occlusion 5.myopic choroidal neovascularization 6.retinopathy of prematurity
For complete deion and other details, please refer to tender
Ranibizumab intra vitreal injection - pfs approved for all indications 1.wet age related macular degeneration 2.diabetic macular edema 3.proliferative diabetic retinopathy 4.retinal vascular occlusion 5.myopic choroidal neovascularization 6.retinopathy of prematurity
For complete deion and other details, please refer to tender
Running contract for inj. ranibizumab (10 mg/ml) (0.23 mg/0.23 ml)for intravitreal injection vial. the medicine should be approved by dcgi for wet armd, diabetic macular oedema, rvo, myopic cnvm, pdr and rop.
For complete deion and other details, please refer to tender
Rc/24-25/246
Supply of pvms no 013409, inj ranibizumab solution for injection 10mg/ml in prefilled
 syringe, each prefilled syringe of 0.1650 ml solution contains ranibizumab 1.650 mg
Rc/23-24256
Supply of of pvms no 013409, inj ranibizumab solution for injection 10mg/ml
 in prefilled syringe each prefilled syringe of 0.1650 ml solution contains ranibizumab 1.650 mg
Need support responding to this opportunity?
Get matched through GetSaarthi for documentation, proposal preparation, compliance readiness, and execution support.
Get Opportunity Matching Supportof your Industry type